Delivery Order SPE2DB24D2100-SPE2DB25FBBTG

Award Date 1/15/25
Potential Completion Date 1/16/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,498.54 firm fixed-price contract is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a pharmaceutical product. The award has an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,169.92, is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a specialty medication. The contract has a ceiling value of $9,169.92 and is a firm fixed-price delivery order, with a completion date of December 24, 2024. AmerisourceBergen Drug Corp is the prime contractor, and there is...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a for-profit pharmaceutical distributor. The $2,825.20 firm fixed-price contract is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML medication. The contract has a ceiling value of $2,825.20 and a completion date of September 10, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through...
This is a $3,769.59 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a diabetes medication. The contract has an ultimate completion date of August 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product VICTOZA 2-PAK 18 MG/3 ML PEN 3ML. The contract has a potential value of $7,528.10 and a completion date of February 20, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value of...
This federal contract award, valued at $1,412.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a diabetes medication. The contract is a firm fixed-price delivery order with a completion date of July 10, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and...
This contract, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The firm fixed price delivery order has a potential value of $1,431.89 and a completion date of February 14, 2024. The contract is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, which serves as the...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceuticals, with a potential value of $3,287.76. The delivery order has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, and no set-aside designation was used. This award is associated with a larger,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Victoza 3-Pak 18 mg/3 ml pen 3 ml. The contract has a firm fixed price of $26,498.98 and a completion date of September 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $5,294.28 firm-fixed-price delivery order is for the supply of 4565170894 - VICTOZA 2-PAK 18 MG/3 ML PEN 3ML, a prescription medication. The contract has an ultimate completion date of July 18, 2024 and was awarded on July 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB25FBBTG
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,529.22, is for the delivery of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML, a prescription medication. The contract has an ultimate completion date of January 16, 2025 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/21/25, 3:54 AM